LLawsuits Nader Pourhassan and Kazem Kazempour March 6, 2023No comments 0 Shares 0 0 0 0 SEC Charges Former Biotech CEO with Fraud, Insider Trading; Research Firm CEO Also Charged in Scheme 0 Shares: Share 0 Tweet 0 Pin it 0 Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Δ
LLawsuits Read More Premium Point Investments LP et al.March 6, 2023 SEC Obtains Judgments and Bar Against Former Hedge Fund CEO Related to Hedge Fund Valuation Scheme
LLawsuits Read More John David Gessin et al.March 14, 2023 On March 14, the Securities and Exchange Commission charged John David Gessin and two of his businesses, Equifunds,…
LLawsuits Read More Cronin and JosephMarch 7, 2023 Litigation Release No. 25493 / September 1, 2022 Securities and Exchange Commission v. Cronin and Joseph, No. 22-mc-248…
LLawsuits Read More Empirex Capital LLC, et al.March 6, 2023 SEC Files Subpoena Enforcement Action Against South Florida Man, His Sister and Their Companies
LLawsuits Read More Syed Arham Arbab, Tomas Javier Jimenez, Blake Douglas McKinney, Mushfiqur Rahman, John Ryan Shows, and William Carl SpagnoliMarch 6, 2023 SEC Charges Incarcerated Felon and Five Friends in $2 Million Fraud Scheme
LLawsuits Read More Christopher S. Kirchner, et al.March 3, 2023 The Securities and Exchange Commission today charged Christopher S. Kirchner, the co-founder and former CEO of Slync, Inc.,…